wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37225463-B1784C42-B2E7-49CD-A3E2-0BE4982A2457
Q37225463-B1784C42-B2E7-49CD-A3E2-0BE4982A2457
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37225463-B1784C42-B2E7-49CD-A3E2-0BE4982A2457
Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer
P2860
Q37225463-B1784C42-B2E7-49CD-A3E2-0BE4982A2457
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37225463-B1784C42-B2E7-49CD-A3E2-0BE4982A2457
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
86d7470295d12ac6f531765c2afad72022d4491e
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.